Novavax Is Angling to Win Over mRNA Defectors
After years of failure, the Maryland company aims to attract the vaccine-hesitant with an alternative to mRNA shots. But will it find a market?
Source: medscape.com
Page 39 - Protein Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Protein Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Protein Sciences Today - Breaking & Trending Today
GLOBAL STUDY DEMONSTRATES ICE3 AND MAURICE CAPILLARY ISOELECTRIC FOCUSING COMPARABILITY IN THE JOURNAL OF ELECTROPHERESIS
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the publication of a global study in the Journal of Electrophoresis: Global Intercompany...
Source: prnewswire.com
Bio-Techne (NASDAQ:TECH) Cut to Hold at Zacks Investment Research
Bio-Techne (NASDAQ:TECH – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, Zacks.com reports. According to Zacks, “Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It […]
Source: etfdailynews.com
Bio-Techne (TECH) – Analysts' Recent Ratings Updates
Several analysts have recently updated their ratings and price targets for Bio-Techne (NASDAQ: TECH): 5/12/2022 – Bio-Techne was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $394.00 price target on the stock. According to Zacks, “Bio-Techne Corporation is a global life sciences company. It […]
Source: etfdailynews.com
BIO-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Jefferies...
Source: prnewswire.com